First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19
…, ST Kiros, A Rocca, F Lagi, MG Colao… - The Journal of …, 2021 - Am Soc Clin Investig
The characterization of the adaptive immune response to COVID-19 vaccination in individuals
who recovered from SARS-CoV-2 infection may define current and future clinical practice. …
who recovered from SARS-CoV-2 infection may define current and future clinical practice. …
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies
…, L Zammarchi, F Lagi, MG Colao… - The Journal of …, 2022 - Am Soc Clin Investig
BACKGROUND Immunization against SARS-CoV-2, the causative agent of COVID-19, occurs
via natural infection or vaccination. However, it is currently unknown how long infection- or …
via natural infection or vaccination. However, it is currently unknown how long infection- or …
Cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2 are lower in asymptomatic than symptomatic COVID‐19 patients
…, M Spinicci, L Salvati, MG Colao… - European Journal of …, 2020 - Wiley Online Library
The characterization of cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2
is fundamental to understand COVID‐19 progression and the development of …
is fundamental to understand COVID‐19 progression and the development of …
Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization
…, L Zammarchi, J Mencarini, MG Colao… - Journal of Clinical …, 2022 - Springer
Background and Purpose Waning immunity and the surge of SARS-CoV-2 variants are
responsible for breakthrough infections, ie, infections in fully vaccinated individuals. Although the …
responsible for breakthrough infections, ie, infections in fully vaccinated individuals. Although the …
Heterogeneous magnitude of immunological memory to SARS‐CoV‐2 in recovered individuals
…, R Semeraro, L Pengue, MG Colao… - Clinical & …, 2021 - Wiley Online Library
Objective Although the adaptive immune response to SARS‐CoV‐2 has been characterised
in the acute and early convalescent phase of the disease, few studies explore whether …
in the acute and early convalescent phase of the disease, few studies explore whether …
[HTML][HTML] AIDS patient with severe T cell depletion achieved control but not clearance of SARS‐CoV‐2 infection
…, M Coppi, N Giovacchini, MG Colao… - European Journal of …, 2022 - ncbi.nlm.nih.gov
A late presenter AIDS patient with severe T cell depletion presented non‐severe COVID‐19
symptoms, with prolonged viral shedding. Our case report supports the hypothesis that an …
symptoms, with prolonged viral shedding. Our case report supports the hypothesis that an …
Epidemiology, management and outcome of varicella in pregnancy: a 20-year experience at the Tuscany Reference Centre for Infectious Diseases in Pregnancy
…, E Venturini, S Giaché, G Sterrantino, MG Colao… - Infection, 2018 - Springer
Data from 215 pregnant women exposed to varicella and 276 with varicella observed at the
Tuscany Reference Center for Infectious Diseases in Pregnancy, Florence, Italy, in the …
Tuscany Reference Center for Infectious Diseases in Pregnancy, Florence, Italy, in the …
Fourth dose of mRNA COVID-19 vaccine transiently reactivates spike-specific immunological memory in people living with HIV (PLWH)
…, P Farahvachi, F Lagi, N Di Lauria, A Rocca, MG Colao… - Biomedicines, 2022 - mdpi.com
Background: People Living With HIV (PLWH), with advanced disease, lower CD4+ T cell
counts or an unsuppressed HIV viral load can have a suboptimal vaccine response. For this …
counts or an unsuppressed HIV viral load can have a suboptimal vaccine response. For this …
A Questionnaire Integrated with the Digital Medical Record Improved the Coverage of a Control Program for Congenital Chagas Disease in Tuscany, Italy
…, GM Rossolini, A Antonelli, P Bordonaro, MG Colao… - Microorganisms, 2023 - mdpi.com
The leading route of Chagas disease transmission in nonendemic countries is congenital.
However, policies concerning screening, prevention, and management of congenital Chagas …
However, policies concerning screening, prevention, and management of congenital Chagas …
The role of baseline HIV‐1 RNA, drug resistance, and regimen type as determinants of response to first‐line antiretroviral therapy
…, G Punzi, MG Colao, G Penco, M Zazzi… - Journal of medical …, 2014 - Wiley Online Library
The factors influencing virological response to first‐line combined antiretroviral therapy (cART)
in an Italian cohort of HIV‐1‐infected patients were examined. Eligible patients were …
in an Italian cohort of HIV‐1‐infected patients were examined. Eligible patients were …
